Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California, USA.
Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.
J Invest Dermatol. 2018 Dec;138(12):2589-2594. doi: 10.1016/j.jid.2018.03.1528. Epub 2018 Jul 2.
Cutaneous squamous cell cancers (cSCCs) present an under-recognized health issue among non-Hispanic whites, one that is likely to increase as populations age. cSCC risks vary considerably among non-Hispanic whites, and this heterogeneity indicates the need for risk-stratified screening strategies that are guided by patients' personal characteristics and clinical histories. Here we describe cSCCscore, a prediction tool that uses patients' covariates and clinical histories to assign them personal probabilities of developing cSCCs within 3 years after risk assessment. cSCCscore uses a statistical model for the occurrence and timing of a patient's cSCCs, whose parameters we estimated using cohort data from 66,995 patients in the Kaiser Permanente Northern California healthcare system. We found that patients' covariates and histories explained approximately 75% of their interpersonal cSCC risk variation. Using cross-validated performance measures, we also found cSCCscore's predictions to be moderately well calibrated to the patients' observed cSCC incidence. Moreover, cSCCscore discriminated well between patients who subsequently did and did not develop a new primary cSCC within 3 years after risk assignment, with area under the receiver operating characteristic curve of approximately 85%. Thus, cSCCscore can facilitate more informed management of non-Hispanic white patients at cSCC risk. cSCCscore's predictions are available at https://researchapps.github.io/cSCCscore/.
皮肤鳞状细胞癌(cSCC)在非西班牙裔白种人群中是一个未被充分认识的健康问题,随着人口老龄化,这一问题可能会加剧。非西班牙裔白种人群中 cSCC 的风险差异很大,这种异质性表明需要根据患者的个人特征和临床病史制定风险分层筛查策略。在这里,我们描述了 cSCCscore,这是一种预测工具,它使用患者的协变量和临床病史为他们分配在风险评估后 3 年内发生 cSCC 的个人概率。cSCCscore 使用了一种用于患者 cSCC 发生和时间的统计模型,其参数是使用 Kaiser Permanente 北加州医疗保健系统的 66995 名患者的队列数据估计的。我们发现,患者的协变量和病史解释了大约 75%的人际 cSCC 风险变异。使用交叉验证的性能指标,我们还发现 cSCCscore 的预测与患者观察到的 cSCC 发生率具有中等程度的校准。此外,cSCCscore 很好地区分了在风险分配后 3 年内是否发生新的原发性 cSCC 的患者,其接受者操作特征曲线下的面积约为 85%。因此,cSCCscore 可以帮助更好地管理 cSCC 风险的非西班牙裔白种患者。cSCCscore 的预测结果可在 https://researchapps.github.io/cSCCscore/ 上获取。